To explore the broader autoimmune profile of the cohort, a comprehensive serologic panel was conducted, including ANAs and myositis-specific antibodies such as anti-Jo-1, anti-Mi2, anti-TIF1γ, anti-MDA5, and others. This evidence concerns the gene TRIM33 and myositis disease.